Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Fall Line Endurance Fund, In Amended 13D Filing, Submitted Preliminary Non-binding Proposal For Greenlight Biosciences For Cash Consideration Of US$0.60/Share

Author: Charles Gross | March 30, 2023 06:15am

https://www.sec.gov/Archives/edgar/data/1675025/000119312523084409/d453299dsc13da.htm

Posted In: GRNA